Kindred Biosciences, Inc. (NASDAQ:KIN)

About the company

Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.

Sector

Health Technology

Industry

Pharmaceuticals: Generic

Employees

156

CEO

Richard H. Chin

Exchange

NASDAQ

Website

http://www.kindredbio.com

$43.00M

Total Revenue

156

Employees

$200.00M

Market Capitalization

-6.49

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$39M

Operating Margin (in %)

Total operating margin

$-25M

Net Margin (in %)

Total net margin

$-30M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Zoetis, Inc. ZTS 77265.60 6340.00 25.67 47.77 25.50
Mylan NV MYL 7641.26 11503.00 0.65 27.89 2.35
Taro Pharmaceutical Industries Ltd. TARO 2112.04 601.00 1.26 -8.25 -42.73
TherapeuticsMD, Inc. TXMD 366.80 63.00 -4.00 -1.92 -304.01
Kindred Biosciences, Inc. KIN 200.00 43.00 2.26 -6.49 -69.69
LifeVantage Corp. LFVN 192.15 233.00 5.52 16.22 4.96
Abeona Therapeutics, Inc. ABEO 137.97 3.00 1.32 -1.47 75.95
Cocrystal Pharma, Inc. COCP 39.20 2.00 1.81 -0.58 -733.84
China Pharma Holdings, Inc. CPHI 16.28 11.00 1.95 -0.80 -183.34
Jaguar Health, Inc. JAGX 4.94 7.00 35.30 0.02 -594.12

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Stock Alert: Kindred Biosciences Gains 17%

5d ago, source: Nasdaq

(RTTNews) - Shares of Kindred Biosciences, Inc. (KIN), are rising more than 17% Wednesday morning after the company, which develops biologics drugs for pets, announced positive results from the ...

Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody

6d ago, source: YAHOO!

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced positive results from a pivotal efficacy study of KIND-030, a ...

Thinking about buying stock in AxoGen Inc, Oasis Petroleum, General Electric, Kopin Corp, or Kindred Biosciences?

5d ago, source: MarketWatch

Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall ...

Kindred Biosciences Inc

1mon ago, source: Reuters

Aug 5 (Reuters) - Kindred Biosciences Inc <KIN.O>::KINDRED BIOSCIENCES ANNOUNCES SECOND QUARTER 2020 FINANCIAL RESULTS.Q2 EARNINGS PER SHARE $0.60.Q2 EARNINGS PER SHARE ESTIMATE $0.00 -- REFINITIV ...

Kindred Biosciences Announces Second Quarter 2020 Financial Results

1mon ago, source: YAHOO!

SAN FRANCISCO, Aug. 5, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial ...

44 Stocks Moving In Tuesday's Mid-Day Session

20d ago, source: MSN

ScanSource, Inc. (NASDAQ: SCSC) fell 12.4% to $21.60 after the company reported worse-than-expected Q4 results. Kindred Biosciences, Inc. (NASDAQ: KIN) tumbled 12.1% to $4.36 after gaining 18% on ...

Kindred Biosciences Inc KIN

11d ago, source: Morningstar%2c Inc.

There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.